Open for bids Tender Germany ICB TOT Ref. 152326716

Conclusion not Excluding Drug Discount Agreement. Tender - 152326716

Tender notice from Germany, published on 11 Nov 2026.

Executive Summary

Title/Summary: Tender for non-exclusive discount agreements for the drug Aflibercept under an Open-House model issued by AOK PLUS – The Health Insurance Fund for Saxony and Thuringia, located in Erfurt, Germany. The tender is open for submissions until December 31, 2027.

Scope Of Work: This tender involves establishing non-exclusive discount agreements for the drug Aflibercept as an injection solution, under the Open-House model. Participation is open to all interested pharmaceutical companies that meet the requirements. The quantity of drug required is uncertain, depending on demand and other factors. Interested parties must apply for access to the project room on the German Procurement Portal (DTVP) to obtain participation documents, which must be kept confidential. The agreements will not guarantee minimum order quantities and will end by December 31, 2027, unless terminated earlier.

Qualification Criterion: Eligible bidders must be pharmaceutical companies that comply with the participation requirements outlined in the project documents available on the DTVP. They must submit a request for access to the project room and adhere to confidentiality regarding the content of the participation documents. All submitted materials must be destroyed if participation is declined. The tender requires electronic communication and document submission through the DTVP portal. Late submissions will be considered at the next deadline.

Key facts

Summary
Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Aflibercept Fer (Atc Code According to Who: S01la05; Except 114.3 Mg/Ml)
TOT Ref. No.
152326716
Document Ref. No.
Login to see
Country
Germany
Notice type
Tender
Competition
ICB
Publication date
11 Nov 2026
Bid deadline
31 Dec 2027
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Tender details are for registered users

Login to see details

Documents

Tender Notice
Login to view

Similar tenders

Germany Public Procurement Intelligence

Frequently asked questions

The last date to submit a bid for Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Aflibercept Fer (Atc Code According to Who: S01la05; Except 114.3 Mg/Ml) is 31 Dec 2027. Submit before this date to be considered.

This tender has been issued by AOK PLUS - THE HEALTH INSURANCE FUND FOR SAXONY AND THURINGIA in Germany.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 152326716. The purchaser document reference is available after login.

See the Similar Tenders section on this page or browse other tenders from Germany.

This tender falls under Materials and Products, Technology and Equipment in Germany. Suppliers in these sectors can track similar Germany tenders using CPV-based alerts.